中英文皆可 — 例如 ALS、阿茲海默、粒線體、TDP-43、財訊Chinese or English — try ALS, Alzheimer, mitochondria, TDP-43
依主題瀏覽Browse by topic
Science News — 論文導讀Science News — Papers2D 圖解 + 3D 動畫 · 9 篇2D + 3D · 9 papers
Science News — 論文導讀(2D 圖解 + 3D 動畫)
-
3D
粒線體斑塊:阿茲海默症中的清除失靈Why do damaged mitochondria accumulate in Alzheimer’s disease?
-
3D
老化與代謝對大腦健康的影響是分開的兩條軸線Aging and metabolism contribute separately to brain-body health
-
3D
粒線體 Complex I 與 ROS 透過相反機制控制神經肌肉功能Mitochondrial Complex I and ROS control neuromuscular function through opposing pre- and postsynaptic mechanisms
-
3D
老化細胞建構大腦屏障Persistent and transient senescent cells contribute to brain-barrier development
-
3D
血液基因表達預測 ALS 疾病狀態與存活Gene expression signatures from whole blood predict amyotrophic lateral sclerosis case status and survival
-
3D
Caspase-4 驅動 TDP-43 細胞質病理Caspase-4, TDP-43 and ALS
-
3D
Alpha-synuclein 類澱粉蛋白作為酵素破壞 ATPα-Synuclein amyloids degrade ATP
-
3D
人類蛋白質體的擴張:微蛋白與 peptideinMicroproteins and peptideins
-
3D
腸道微生物與大腦健康的雙向對話Bidirectional crosstalk between the gut microbiota and cellular compartments of brain: Implications for neurodevelopmental and neuropsychiatric disorders
Science News — 論文報告Science News — Reports4 篇4 reports
Science News — 論文報告
-
Rhamnazin 透過 BDNF-ERK 路徑改善阿茲海默症模型認知障礙Rhamnazin attenuates amyloid-β induced spatial memory impairment
-
APOE ε2 與 ε4 的蛋白質組學特徵與阿茲海默症Proteomic signatures of the APOE ε4 and ε2 variants in Alzheimer's disease
-
RNA 療法治療阿茲海默症與 Tau 蛋白病變RNA-based therapeutics for Alzheimer's disease and related tauopathies
-
阿茲海默症藥理學新紀元:抗澱粉樣蛋白與非澱粉樣蛋白標靶A new era in neuropharmacology: amyloid and non-amyloid targets